Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−53.65 MXN
−1.05 B MXN
204.82 M MXN
14.66 M
About Accelerate Diagnostics, Inc.
Sector
Industry
CEO
Jack Phillips
Website
Headquarters
Tucson
Founded
1982
FIGI
BBG00PC2K432
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AXDX is 38.10 MXN — it has increased by 90.50% in the past 24 hours. Watch ACCELERATE DIAGNOSTICS, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ACCELERATE DIAGNOSTICS, INC stocks are traded under the ticker AXDX.
AXDX stock has fallen by −0.96% compared to the previous week, the month change is a 83.35% rise, over the last year ACCELERATE DIAGNOSTICS, INC has showed a 115.62% increase.
AXDX stock is 48.48% volatile and has beta coefficient of −0.09. Track ACCELERATE DIAGNOSTICS, INC stock price on the chart and check out the list of the most volatile stocks — is ACCELERATE DIAGNOSTICS, INC there?
Today ACCELERATE DIAGNOSTICS, INC has the market capitalization of 831.01 M, it has increased by 2.33% over the last week.
Yes, you can track ACCELERATE DIAGNOSTICS, INC financials in yearly and quarterly reports right on TradingView.
ACCELERATE DIAGNOSTICS, INC is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
AXDX earnings for the last quarter are −10.71 MXN per share, whereas the estimation was −9.29 MXN resulting in a −15.35% surprise. The estimated earnings for the next quarter are −10.32 MXN per share. See more details about ACCELERATE DIAGNOSTICS, INC earnings.
ACCELERATE DIAGNOSTICS, INC revenue for the last quarter amounts to 58.62 M MXN, despite the estimated figure of 59.60 M MXN. In the next quarter, revenue is expected to reach 62.14 M MXN.
AXDX net income for the last quarter is −288.44 M MXN, while the quarter before that showed −212.55 M MXN of net income which accounts for −35.71% change. Track more ACCELERATE DIAGNOSTICS, INC financial stats to get the full picture.
No, AXDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 134.00 employees. See our rating of the largest employees — is ACCELERATE DIAGNOSTICS, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACCELERATE DIAGNOSTICS, INC EBITDA is −683.26 M MXN, and current EBITDA margin is −421.05%. See more stats in ACCELERATE DIAGNOSTICS, INC financial statements.
Like other stocks, AXDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACCELERATE DIAGNOSTICS, INC stock right from TradingView charts — choose your broker and connect to your account.